Last reviewed · How we verify
NCT04596059: Friso02
The Journey of Children With Cow's Milk Protein Allergy in Mexico.
trial testing Frisolac Gold Intensive HA in Cow's Milk Protein Allergy in 79 participants. Completed in 31 May 2021.
31 May 2021
Quick facts
| Lead sponsor | FrieslandCampina |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 79 |
| Start date | 1 October 2020 |
| Primary completion | 31 May 2021 |
| Estimated completion | 31 May 2021 |
| Sites | 4 locations across Mexico |
Drugs / interventions tested
- Frisolac Gold Intensive HA
Conditions studied
- Cow's Milk Protein Allergy — all drugs for Cow's Milk Protein Allergy →
Sponsor
FrieslandCampina — full company profile →
Who can join
Adults 0 Months to 24 Months, any sex, with Cow's Milk Protein Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To gain insights on the application, use and effectiveness of Frisolac Gold Intensive HA and Frisolac Gold PEP AC with reference to improvement of CMPA symptoms and to determine the methodology used by Mexican Health Care Professionals (HCPs) in the clinical practice (i.e. diagnosis and dietary management) of CMPA in Mexican children (≤24 months) diagnosed with or suspected of CMPA.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Symptom's resolution and growth outcome of children with cow's milk protein allergy consuming two hydrolyzed formulas: A retrospective study in Mexico.
Estrada Reyes E, Zepeda Ortega B, Ten Haaf D, Kudla U, et al · · 2023 · cited 1× · PMID 36793546 · DOI 10.3389/falgy.2023.1073430
Verify or expand the search:
- PubMed search for NCT04596059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cow's Milk Protein Allergy
Currently open trials in the same condition.
- NCT07448740 — Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational · recruiting
Other FrieslandCampina trials
Trials by the same sponsor.
- NCT07242508 — Efficacy of a New Infant Formula Composition on Gut Health in Infants · NA · not yet recruiting
- NCT06251427 — Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-ag · NA · completed
- NCT05813769 — Dairy and Plant Amino Acid Uptake. An Explorative Study · NA · completed
- NCT05670002 — Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children · NA · completed
- NCT05418491 — The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the De · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04596059 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FrieslandCampina
- Last refreshed: 27 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04596059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing